The Journal of Nuclear Medicine - JNM’s Post

Editor’s Choice: Ah Young Lee and colleagues describe "Efficacy and safety of MC-003 solution for endoscopic mucosal or submucosal resection: a prospective, multicenter, randomized, triple-blinded, parallel-group, phase III study." Find it at https://lnkd.in/g3Ruytf6. Also read the editorial by Emmanuel Coronel, "A new kid on the 'bloc'? A case for another submucosal injection agent for endoscopic resection of early gastric neoplasms."

Say hello to Tina Baker, pinch-hitting for Kevin Hale, at tomorrow's spring meeting of American Association of Physicists in Medicine MRV Chapter! Learn about myQA® SRS, your digital SRS/SBRT Patient QA solution: https://lnkd.in/eYQd5gT6 #MedicalPhysics #RadiationTherapy #MedPhys #Dosimetry IBA Dosimetry

Dear Friends, hope you like this clinical paper which is the first report who clearly shows a practical use of 55° SD-OCT for the follow up of patients operated for retinal detachment. As you could read in the manuscript, you can find some tips to follow any peripheral fluid remnants in patients operated either with buckle or with vitrectomy. This is a not invasive technique that could prevent re-operation of these patients where there is a doubt for recurrence or a failure of any type or Retinal detachment.

Looking for ways to improve your endoscopic polyp resection? Discover the secrets to achieving complete pathologic resection with clear margins in this medical video: https://lnkd.in/ev3t8hgd

Looking for ways to improve your endoscopic polyp resection? Discover the secrets to achieving complete pathologic resection with clear margins in this medical video: https://lnkd.in/ev3t8hgd

Looking for ways to improve your endoscopic polyp resection? Discover the secrets to achieving complete pathologic resection with clear margins in this medical video: https://lnkd.in/ev3t8hgd

Seeking help regarding a challenging case of recurrent in-stent restenosis that has proven resistant to conventional management. The patient has experienced three episodes of in-stent restenosis affecting two different coronary territories, despite sequential trials of multiple P2Y12 inhibitors (Brilinta, Effient, and Plavix) with confirmed good compliance. IVUS evaluation demonstrates optimal stent deployment with good expansion, proper wall apposition, and no identifiable mechanical issues. Despite optimized medical therapy and proper stent deployment, we continue to see recurrent ISR. What is your suggestion ?

Looking for ways to improve your endoscopic polyp resection? Discover the secrets to achieving complete pathologic resection with clear margins in this medical video: https://lnkd.in/ev3t8hgd

Looking for ways to improve your endoscopic polyp resection? Discover the secrets to achieving complete pathologic resection with clear margins in this medical video: https://lnkd.in/ev3t8hgd

#Tricuspip field is moving quickly for the best of our patients! Beyond the direct comment of #TRISCENDII Edwards Lifesciences, recently presented at #TCT2024 Cardiovascular Research Foundation, you can find here the considerations of Prof Kodali Susheel about the #future of this field! 🔭 💫 Feel free to have a look at the report too 📰 : https://lnkd.in/dxZ2Rbmy #PCRTricuspid #TTVR PCR